The XmnI and BCL11A Single Nucleotide Polymorphisms May Help Predict Hydroxyurea Response in Iranian β-Thalassemia Patients

Mehdi BananGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IranCorrespondence[email protected]

Hadi BayatGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Azita AzarkeivanBlood Transfusion Organization, Tehran, Iran;The Adult β-Thalassemia Clinic, Tehran, Iran

Saeid MohammadparastGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Koorosh KamaliReproductive Biotechnology Research Center, Avicenna Research Institute, Tehran, Iran

Samaneh FarashiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Nooshin BayatKariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran

Masumeh Hadavand KhaniThe Adult β-Thalassemia Clinic, Tehran, Iran

Maryam NeishaburyGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Hossein NajmabadiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran;Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran

show all

The XmnI and BCL11A Single Nucleotide Polymorphisms May Help Predict Hydroxyurea Response in Iranian β-Thalassemia Patients

Supplementary Table 1 – Good Responders (patients 1–37)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The XmnI and BCL11A Single Nucleotide Polymorphisms May Help Predict Hydroxyurea Response in Iranian β-Thalassemia Patients

Supplementary Table 1 – Good Responders (patients 1–37)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date